Connaughton Bernadette Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$294,736.24

Insider Activity of Connaughton Bernadette

According to the SEC Form 4 filings, Connaughton Bernadette, being in a position of

  1. director at Halozyme Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 11330 shares for $839,366,
    over all time since 2025-09-02, has bought 0 shares, and sold 17330 shares for $1.28M.

Biography of Connaughton Bernadette

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $839,3667100

Comparison of Insiders on Amount of Buys and Sells

2026-08-10SaleHalozyme Therapeutics, Inc.
HALO
director
1,626
0.0014%
$102.80$167,153+7.05%
2026-07-01SaleHalozyme Therapeutics, Inc.
HALO
director
1,625
0.0014%
$76.71$124,651+39.75%
2026-06-01SaleHalozyme Therapeutics, Inc.
HALO
director
1,625
0.0013%
$66.21$107,591+54.27%
2026-05-01SaleHalozyme Therapeutics, Inc.
HALO
director
1,625
0.0014%
$63.48$103,155+30.58%
2026-01-05SaleHalozyme Therapeutics, Inc.
HALO
director
2,000
0.0017%
$70.25$140,500+2.85%
2025-12-01SaleHalozyme Therapeutics, Inc.
HALO
director
829
0.0007%
$71.60$59,356+5.27%
2025-11-10SaleHalozyme Therapeutics, Inc.
HALO
director
2,000
0.0017%
$68.48$136,960+5.04%
2025-10-01SaleHalozyme Therapeutics, Inc.
HALO
director
2,000
0.0018%
$75.24$150,481-6.55%
2025-09-02SaleHalozyme Therapeutics, Inc.
HALO
director
4,000
0.0034%
$73.68$294,736-4.47%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.